Powered by Axial Data

Top Pharmaceuticals Private Equity Funds

Explore 201 Pharmaceuticals Private Equity Funds that source acquisition and investment opportunities on Axial’s M&A platform.

Axial Insights

Pharmaceuticals Private Equity Funds

201

Active Firms

14,250

TTM Deal Inquiries

$3M-$19M

Core Revenue Range

$800K-$4M

Core EBITDA Range


Florida 14%
California 11%
Texas 10%
New York 7%
New Jersey 4%

Focus: Control Investments | Capital Source: Committed Capital | Operating Approach: Scale & Exit

Showing 21-40 of 201 Private Equity Funds

Sorted by recent activity

Greybull Stewardship

1 Closed Deal via Axial 24 Total Closed Deals Actively Sourcing Deals
Greybull Stewardship is founded, funded, and run by business owners and managers. Our fund is structured to allow the power of permanence to impact the value of an investment, we have no mandate to sell. We have committed capital to support current ownership's growth and liquidity needs. Greybull is actively seeking new investments and our investment horizon is long term. We do not mandate growth rates and with our history as owners and managers, we know how to assist businesses and also stay out of the way.

Recent Transactions

View All
  • Mar 2023 Acquired Courtroom Connect
  • Aug 2022 Acquired Coastline Academy
  • Sep 2021 Acquired JTB Custom
  • Aug 2021 Acquired LINC

Envest Capital Partners

1 Closed Deal via Axial 22 Total Closed Deals Actively Sourcing Deals
Envest Capital Partners is an investment company holding long term private equity positions in established basic businesses. We invest in a relatively broad range of basic industries, with a focus on manufacturing, industrial & consumer services, and franchising. Envest seeks to provide private direct equity financing to companies with sales of $5 to $50 million, exceptional growth prospects and strong, stable cash flow. Founded in 2000, Envest is a private equity firm based in Virginia Beach, VA. We are dedicated to partnering with privately held and founder-owned businesses. The Envest…

Recent Transactions

View All
  • Aug 2023 Acquired Earl Industries Inc.
  • Aug 2023 Acquired Digital Services LLC
  • Aug 2023 Acquired Commonwealth Epoxy Coatings LLC
  • Oct 2022 Acquired CBT Logistics Group

Presidio Investors

1 Closed Deal via Axial 16 Total Closed Deals Actively Sourcing Deals
Presidio Investors is a leading middle market private equity firm based in Austin, Texas that partners with growing, niche businesses in the business services and entertainment sectors. The Presidio team has significant investing and operating experience, and they employ a collaborative approach to help grow and develop businesses to produce excellent returns for all stakeholders.Please see our website www.presidioinvestors.com for more information.

Recent Transactions

View All
  • Apr 2026 Acquired Confidential Company
  • Aug 2021 Acquired Centennial Media
  • Apr 2021 Acquired Resolve Tech Solutions
  • Aug 2019 Acquired Bravas

Crescendo Capital Partners

1 Closed Deal via Axial 15 Total Closed Deals Actively Sourcing Deals
Crescendo Capital Partners is a private equity firm based in Los Angeles. Crescendo is primarily focused on middle-market change-of-control transactions, typically with enterprise values from $10M-$100M. While industry generalists, we have specific operating resources in the following fields, which help source, vet, manage and/or oversee portfolio companies: * construction/trades* healthcare * food/beverage/nutra * outsourcing/staffing * light distribution* retail/distribution * packaging/consumer products We are a very actively engaged private equity partner across strategy, operations and…

Recent Transactions

View All
  • Aug 2023 Acquired Montbleau
  • Aug 2022 Acquired AGS Construction
  • Aug 2021 Acquired Calm Waters Pool Services
  • Aug 2021 Acquired Pools on the Gulf

The Edgewater Funds

1 Closed Deal via Axial 15 Total Closed Deals Actively Sourcing Deals
Through Edgewater Growth Capital Partners, we partner with management to help accelerate growth in their businesses. Edgewater focuses on funding high quality middle market companies where we can add substantial value through our capital, our experience and our broad network.

Recent Transactions

View All
  • Oct 2025 Acquired Confidential Company
  • Nov 2024 Acquired NYX Health Eligibility Services
  • Aug 2024 Acquired Nationwide Coils, Inc.
  • Jul 2024 Acquired Silver State Refrigeration & HVAC

Chicago Capital Partners

1 Closed Deal via Axial 12 Total Closed Deals Actively Sourcing Deals
Chicago Capital Partners is a private equity firm which primarily makes control investments in lower middle-market companies with $2-10 million of EBITDA in the following industries: business services, consumer products, distribution, food and beverage, and niche manufacturing. Our fund structure and investment mindset promote building business partnerships and creating value over the long-term.Operational Perspective: Managed by founders and operators, our team understands small and family business dynamics;Partnership Focused: We partner with strong management teams, provide…

Recent Transactions

View All
  • Apr 2025 Acquired Confidential Company
  • Feb 2022 Acquired Nickerson
  • Jun 2021 Acquired Chocolate Works
  • Dec 2020 Acquired Home Sweet Home

Stop Browsing. Start Transacting.

Join 20,000+ members who source deals, connect with counterparties, and close transactions on Axial.

Latticework Capital

1 Closed Deal via Axial 12 Total Closed Deals Actively Sourcing Deals
Latticework Capital OverviewHeadquartered in Dallas, Latticework Capital Management is a growth-oriented private equity firm focused exclusively on the healthcare industry with over $400 million of assets under management. Latticework leverages its over 100 combined years of healthcare and investing experience as well as its network of industry executives to help companies grow and realize their full, long-term value. For more information visit www.latticeworkcapital.com.Healthcare FocusCompetition in private equity is driving fund specialization. Similar to other large and evolving…

Recent Transactions

View All
  • Jun 2025 Acquired First Medical Associates
  • Dec 2024 Acquired Life Science Connect
  • Sep 2023 Acquired Institutes of Health
  • Aug 2022 Acquired AMERICAN CLINICAL RESEARCH SERVICES

Castle Capital

1 Closed Deal via Axial 10 Total Closed Deals Actively Sourcing Deals
Castle Capital is focused on environmental services in lower middle market private equity. We have successfully invested (and exited) companies in the recycling space and are looking at other environmental services sectors as well.

Recent Transactions

View All
  • Nov 2025 Acquired Confidential Company
  • Nov 2024 Acquired Tire Depot
  • Nov 2024 Acquired Ray's Tire
  • Nov 2024 Acquired Dietrich Tire Waste Hauling

PennSpring Capital

1 Closed Deal via Axial 10 Total Closed Deals Actively Sourcing Deals
Investment OverviewPennSpring Capital is actively seeking acquisitions of lower-middle-market businesses where founders are looking for a trusted partner to ensure long-term continuity, professionalize operations, and support the next stage of growth. We move quickly, close reliably, and customize structures to meet seller goals.We have a strong track record across compliance-oriented software, environmental services, B2B services, and niche recurring-revenue businesses.Target CriteriaIndustry Focus (any of the following):Environmental services (asbestos, mold,…

Recent Transactions

View All
  • Aug 2023 Acquired EHC
  • Aug 2023 Acquired Yapstone
  • Aug 2023 Acquired Circle
  • Aug 2023 Acquired total traffic service

Fusion Capital Partners

1 Closed Deal via Axial 5 Total Closed Deals Actively Sourcing Deals
Fusion Capital Partners is a Los Angeles based private equity firm pursuing investments in engineered products and essential services businesses across the commercial and industrial markets of North America

Recent Transactions

View All
  • Jul 2026 Acquired Confidential Company
  • Mar 2026 Acquired Confidential Company
  • Jun 2025 Acquired Arkansas Industrial Machinery
  • May 2025 Acquired Relevant Industrial

Gemini Investors

136 Total Closed Deals Actively Sourcing Deals
Founded in 1993, Gemini Investors is a Massachusetts-based private equity firm that provides capital and strategic resources to lower middle market companies. Since its inception, we have invested approximately $1 Billion in more than 185 companies throughout the U.S., typically investing $3 – $8 million per transaction in either control or minority positions. Gemini offers a flexible investment approach. We provide a wide range of financing structures, which include subordinated debt with warrants, preferred stock, and common equity. We have extensive experience leading transactions, as…

Recent Transactions

View All
  • Sep 2025 Acquired Party Reflections
  • May 2025 Acquired Honey Smoked Fish
  • May 2025 Acquired Gold Coast Baking Company
  • Feb 2025 Acquired Spectro-UV

Forsyth Partners

94 Total Closed Deals Actively Sourcing Deals
BW Forsyth Partners is a private investment firm located in St. Louis, Missouri. Our approach differs from those typically utilized by other investment or private equity firms in that Forsyth Partners is a long-term investor (we do not exit our investments) looking to build strong companies through operational focus, an active acquisition effort and, most importantly, a focus on the best interests of all stakeholders of its portfolio companies. Forsyth partners directly with businesses in an effort to develop sustainable performance over the long-term, promote a people-centric culture, and…

Recent Transactions

View All
  • Sep 2023 Invested in WalkerHughes
  • Aug 2023 Invested in Afinitas
  • Mar 2023 Invested in Cor Partners
  • Jan 2021 Invested in Machine Solutions Inc.

Gen Cap America

57 Total Closed Deals Actively Sourcing Deals
Gen Cap America (GCA) is a private equity firm headquartered in Nashville, Tennessee that specializes in leveraged buyouts of privately held lower-middle market businesses. Investment Criteria: Revenue: $5M - $100MEBITDA: $1.5M - $10M Geography: United States & CanadaTransaction Types: Family SuccessionManagement BuyoutDivisional Spin-offRecapitalizationsMost transactions are management buyouts or buyouts of one or multiple retiring owners. GCA target investments typically have a long history of successful operations and cash flow, and quality managers who wish to be part of the…

Recent Transactions

View All
  • Feb 2022 Acquired Aquasol Corporation
  • Sep 2021 Invested in Lab Products, Inc.
  • Jan 2021 Acquired Frontier Packaging, Inc.
  • Sep 2020 Acquired TFM Services, LLC

Graham Partners

46 Total Closed Deals Actively Sourcing Deals
Graham Partners is a private investment firm focused on investing in businesses with proprietary technologies, advanced manufacturing know-how, innovative product development capabilities, and strong growth potential. Graham Partners targets companies with EBITDA between $5 million and $50 million, and will invest in smaller companies to the extent they complement one or more of its other holdings. Since the firm's founding in 1988, Graham Partners has closed over sixty acquisitions, joint ventures, financings, and divestitures. The committed capital raised since inception through the Graham…

Recent Transactions

View All
  • Sep 2023 Acquired Barcoding
  • Sep 2023 Acquired Commercial Bakeries Corp.
  • Aug 2023 Acquired TAOGLAS
  • Mar 2023 Acquired Rhythmlink

Clearview Capital

45 Total Closed Deals Actively Sourcing Deals
We are a private investment firm specializing in control and non-control investments of North American companies with operating profits of $4 - $20 million.Since the firm’s founding in 1999 by Jim Andersen, Calvin Neider and Pete Doolittle, Clearview has single-mindedly remained dedicated to investing in and supporting the development of lower middle market companies. Working collaboratively with our portfolio company management teams, we provide targeted strategic and operational assistance, as well as capital, to fuel organic and acquisition growth initiatives.Since inception, the…

Recent Transactions

View All
  • Jan 2025 Acquired Loss Prevention Services
  • Dec 2023 Acquired AdCellerant
  • May 2023 Acquired Inventive
  • Apr 2023 Acquired Capitol Services

Hammond Kennedy Whitney & Company

44 Total Closed Deals Actively Sourcing Deals
HKW is evolving with clarity and purpose, while honoring the vision of the firm’s founders and our 100 plus year history. We focus on specific sectors in which we can utilize our skills and perspective, leveraging technology as part of a data-driven methodology to power our “Four Pillar” structure. HKW has developed processes that support our strategy to find, create, and sustain value in our companies while trusting and appreciating that our approach is what sets us apart.

Recent Transactions

View All
  • Jan 2023 Acquired CMIT Solutions
  • Dec 2022 Acquired dominKnow
  • Sep 2022 Acquired Golden Country Oriental Food
  • Mar 2022 Invested in Draup

Stonehenge Partners

42 Total Closed Deals Actively Sourcing Deals
Stonehenge Partners ("Stonehenge" or the "Firm") is a middle-market private equity firm with a highly successful 25+ year track record. The Firm directs the investment activities for approximately $1 billion in capital commitments. Stonehenge's investment professionals have extensive experience executing a broad range of transactions including:Management and leveraged buyoutsAcquisitionsRecapitalizationsGrowth capital investmentsStonehenge Partners has the flexibility to invest in a variety of structures including common equity, preferred equity and subordinated debt (or combinations…

Recent Transactions

View All
  • Jun 2019 Invested in Carolina Restaurant Group, Inc.
  • Apr 2019 Invested in Weil Foot & Ankle Institute
  • Jan 2019 Acquired PPM Technologies
  • Sep 2018 Acquired EMX Industries, Inc.

Rockwood Equity Partners

41 Total Closed Deals Actively Sourcing Deals
Rockwood Equity Partners:B2B manufacturing, service providers, distribution in industrials and regulated industries (e.g., healthcare, aerospace & defense, environmental, waste, rail, water, others)Transaction types: First institutional capital partner, majority, minority, growth, independent sponsor and operator partners, management buyout, corporate divestitureTarget company size: $10-$75 million in revenues and $2-$7 million EBITDA, add-ons of any size.Private equity investment firm for lower middle market companies, with a track record spanning 25+ years.Approach:Focused on growing…

Recent Transactions

View All
  • Dec 2025 Acquired Wright's Hydroseeding
  • Dec 2025 Acquired Utility Locating Services in Ohio
  • Nov 2025 Acquired Sealer Equipment Business serving Medical and Pharmaceutical
  • Sep 2024 Acquired SafeSite

The Brydon Group

38 Total Closed Deals Actively Sourcing Deals
The Brydon Group is a veteran-led $500M+ private equity fund focused on acquiring recurring revenue small businesses with $1-$5M EBITDA. To date we've closed 39 transactions. We are an ideal solution for owners looking to transition their legacy to the next generation of small business owner as we bring in one of our industry-focused entrepreneurs-in-residence as CEO.We have a focus on software and B2B, government, & healthcare services.Investor team consists of Alex Mears (two decades in large cap private equity at Blackstone and Carlyle and five years in Special…

Recent Transactions

View All
  • Jan 2026 Acquired Confidential Company
  • Dec 2025 Acquired Confidential Company
  • Dec 2025 Acquired Confidential Company
  • Dec 2025 Acquired Confidential Company

Renovus Capital Partners

36 Total Closed Deals Actively Sourcing Deals
Founded in 2010, Renovus Capital Partners is a private equity firm specializing in the Knowledge and Talent industries. Renovus, based in the Philadelphia area, manages over $1 billion across three sector focused PE funds and one generalist strategy (RCap). The firm’s current portfolio includes over 25 U.S. based businesses specializing in education and training, B2B healthcare services, technology services and professional services. Renovus typically partners with founder-led businesses, leveraging its industry expertise and access to debt and equity capital to make operational…

Recent Transactions

View All
  • Aug 2023 Acquired quiktrak
  • Aug 2023 Acquired Modality Solutions
  • Jul 2023 Acquired Procomputing
  • Jun 2023 Acquired Oakbrook Solutions

Frequently Asked Questions

How are Private Equity Funds in this directory ordered?

Firms in the Pharmaceuticals Private Equity Funds directory are ordered based on recent deal activity on Axial. The default order reflects observed market signals rather than a subjective ranking of firm quality.

What information is included in each Private Equity Fund profile?

Each profile provides information about the firm’s areas of focus, transaction criteria, and relevant activity on Axial’s M&A platform. Together, these details provide a clearer view of where a firm is active and the types of companies and opportunities most relevant for it.

What company sizes are most common for Pharmaceuticals Private Equity Funds?

Based on activity on Axial’s M&A platform, the core revenue range for Pharmaceuticals Private Equity Funds is $3M-$19M, with a core EBITDA range of $800K-$4M. Company size can be an important indicator of fit, as firms often concentrate their experience, resources, and transaction activity within particular segments of the market.

How important is Life Sciences experience when evaluating Private Equity Funds?

Relevant Life Sciences experience can be an important consideration when evaluating a firm. Familiarity with the sector can provide a stronger understanding of its business models, market dynamics, valuation considerations, and transaction environment. The 201 firms included in this directory provide a starting point for identifying firms with relevant experience and activity in Life Sciences.

Do all Private Equity Funds in this directory focus exclusively on Life Sciences?

Not necessarily. Many firms are active across multiple industries, so inclusion in the Pharmaceuticals Private Equity Funds directory reflects relevant experience or activity in Life Sciences, rather than an exclusive sector focus. Individual profiles provide additional context on each firm’s areas of focus and activity within the sector.

How do I compare Private Equity Funds with experience in Life Sciences?

When comparing Private Equity Funds with experience in Life Sciences, consider factors such as size range, geographic reach, and recent transaction activity. These characteristics vary across the 201 firms included in the directory and can help identify firms that align with your needs.

How do I connect with Pharmaceuticals Private Equity Funds?

Axial can help you identify and connect with firms based on your objectives and what you are looking to accomplish. The process varies depending on your role and transaction needs. If you are interested in connecting with firms in the Pharmaceuticals Private Equity Funds directory, you can request information here.


Want to Keep Exploring?

Enter your details to access all firm profiles.

Let us curate Relevant Introductions.

Rather than a one-off introduction to company, work with an Axial Exit Consultant to find the best options from our network of 2,500 M&A advisors — at no cost to you.

Companies sold using Axial Advisor Finder:

Get Introduced to the Right Advisors

This service is complimentary and all information is confidential. Looking to learn more? Complete the form above.

By providing telephone number and submitting the form you are consenting to be contacted by SMS text message. Message & data rates may apply. Reply STOP to opt of further messaging.

We've Received Your Request

A member of our team will follow up to coordinate next steps.

Explore Axial
Template